Selected publications

- Click here for a full list.

Aceto N, Toner M, Maheswaran S, Haber DA. “En route to metastasis: circulating tumor cell clusters and epithelial-to-mesenchymal transition”. Trends in Cancer - Cell press (inaugural issue). 2015 Sep 1.

Sarioglu FA*, Aceto N*, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan T, Miyamoto DT, Luo X, Bardia A, Wittner BS, Ramaswamy S, Shioda T, Ting DT, Stott SL, Kapur R, Maheswaran S, Haber DA and Toner M. “A microfluidic device for label-free, physical capture of circulating tumor cell clusters”. *Equal contribution. Nature Methods. 18 May 2015. PMID: 25984697

Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M, Haber DA and Maheswaran S. “Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis”. Cell. 2014 Aug 28. PMID: 25171411

Awards and citations: Abstract Award at Massachusetts General Hospital Cancer Center (2014), Advances of the Year in Basic Research at San Antonio Breast Cancer Symposium (2014), Martin Prize for Basic Research at Massachusetts General Hospital (2014). Highlighted in (selected): Nature (2014), Nature Reviews Cancer (2014), Cancer Discovery (2014), Massachusetts General Hospital press (2014), NCI - National Cancer Institute (2014), American Society of Clinical Oncology (2014), WN - World News Network (2014).

Yu M, Bardia A, Aceto N, Bersani F, Madden MN, Donaldson MC, Desai R, Comaills V, Zheng Z, Brachtel E, Sgroi D, Kupur R, Getz G, Iafrate AJ, Benes C, Toner M, Maheswaran S and Haber DA. “Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility”. Science. 2014 Jul 11. PMID: 25013076 

Highlighted in (selected): Nature Reviews Cancer (2014), Nature Reviews Drug Discovery (2014), Nature Reviews Clinical Oncology (2014), Cancer Discovery (2014), Massachusetts General Hospital press (2014), Boston Globe (2014), NCI - National Cancer Institute (2014).

Aceto N, Sausgruber N, Brinkhaus H, Gaidatzis D, Martiny-Baron G, Mazzarol G, Confalonieri S, Quarto M, Hu G, Balwierz P, Pachkov M, Elledge SJ, van Nimwegen E, Stadler MB, and Bentires-Alj M. “Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop”. Nature Medicine. 2012 Mar 4. PMID: 22388088

Awards and citations: Best publication of the year, Basel Stem Cell Network (2012), Cited by James Watson in “Oxidant, antioxidants and the current incurability of metastatic cancers” (2013). Highlighted in (selected): Breast Cancer Research (2012).

Aceto N, Duss S, Macdonald G, Meyer DS, Roloff TC, Hynes NE and Bentires-Alj M. “Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion”. Breast Cancer Research. 2012 Oct 12. PMID: 23062209

Awards and citations: Highly-accessed, Breast Cancer Research (2012)

Sun T, Aceto N, Meerbrey KL, Kessler JD, Zhou C, Migliaccio I, Nguyen DX, Pavlova NN, Botero M, Huang J, Bernardi RJ, Schmitt E, Hu G, Li MZ, Dephoure N, Gygi SP, Rao M, Creighton CJ, Hilsenbeck SG, Shaw CA, Muzny D, Gibbs RA, Wheeler DA, Osborne CK, Schiff R, Bentires-Alj M, Elledge SJ, Westbrook TF. “Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase”. Cell. IF=33.116. 2011 Mar 4. PMID: 21376233

Highlighted in (selected): Cell (2012).